跳至主要内容
临床试验/NCT02679677
NCT02679677已完成不适用

Evaluation of the Effects of Whole Body Vibration Training With the Galileo Training Device on the Lung Function of Patients With Stable COPD

Heidelberg University2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2015年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
2
主要终点
FEV1

研究概览

简要总结

The typical clinical progression of COPD usually results in a decreased level of tolerable physical exertion for the patient. The avoidance of strenuous physical activity leads to a deteriorating level of physical fitness, which further decreases the patient's ability to undertake physical activities. Recent research has shown that whole body vibration has the potential to improve physical fitness of participants, including such measures as the 6 minute walking distance. However, information concerning lung function is lacking.

The goal of the study is to test whether the use of whole body vibration training has an effect on the lung function of patients with stable COPD, or if the previously observed effects can be attributed to either pharmaceutical therapy or physical therapy interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Stable COPD (Gold II-IV)
  • •Signed understanding of participation
  • •The patients must be able to understand and follow the requirements of participation (Understanding of the German language)

排除标准

  • •Acute thrombosis
  • •Hemoptysis
  • •Implants in the targeted training regions (joint implants)
  • •Acute joint inflammation, active arthrosis or arthropathy.
  • •Rheumatoid arthritis
  • •Acute tendinopathy in the targeted training regions
  • •Acute hernia
  • •Acute discopathy
  • •Fresh fracture in the targeted training regions
  • •Gall or kidney stones
  • •Wounds still in the process of healing
  • •Severe neurologic disorders (apoplexy, paralysis of upper and lower extremities)
  • •Severe circulatory disorders (Cardiac insufficiency NYHA > or = III, myocardial infarct less than one month prior, circulatory relevant rhythm disorders, idiopathic syncope)
  • •Tension pneumothorax
  • •Acute internal bleeding
  • •Current therapy with fluoroquinolone
  • •Alcohol/drug/medication abuse

研究组 & 干预措施

Control

Sham Comparator

Whole body vibration training as sham procedure (5Hz) 3 times a week, 3x2 minutes, for 6 weeks.

干预措施: Whole Body Vibration (Device)

Intervention

Experimental

Whole body vibration training (12 Hz up to 30 Hz) 3 times a week, 3x2 minutes, for 6 weeks.

干预措施: Whole Body Vibration (Device)

结局指标

主要结局

FEV1

时间窗: Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2)

次要结局

  • PHQ-9 (Brief Patient Health Questionnaire(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • SGRQ-C: Saint George´s Respiratory Questionnaire for COPD Patients(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • Maximal inspiratory pressure(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • Handheld Dynamometry Strength Testing of Extremities(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • Diffusion capacity for oxygen(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • SF-12: Short Form (12) Health Questionnaire(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • CAT: COPD Assessment Test(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • mMRC: Modified British Medical Research Council(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • 6 Minute Walking Test(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))
  • Chair Rising Test(Baseline (T0), Change from baseline measured at end of six weeks of training (T1), Change from baseline measured at six week follow-up measurement (T2))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Felix JF Herth

Medical Director

Heidelberg University

研究点 (2)

Loading locations...

相似试验